In addition, we evaluated the lymphocyte levels (immune cell score, IS) in the tumours using the same principle as Immunoscore®, which derives from the densities of CD3+ and CD8+ lymphocytes in the tumour centre and invasive margins, a new prognostic marker in CRC. Here, CD8A is linked to neoplasm.